Mary Lynne Hedley Eli Lilly & CO (LLY) insider trading activity

Mary Lynne Hedley is Director of ELI LILLY & Co. Currently has a direct ownership of 1,878 shares of LLY, which is worth approximately $1.49 Million. The most recent transaction as insider was on Nov 21, 2022, when has been sold 359 shares (Common Stock) at a price of $361.17 per share, resulting in proceeds of $129,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.88K

22.19% 3M change

32.16% 12M change

Total Value Held $1.49 Million

Mary Lynne Hedley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2022	BUY Grant, award, or other acquisition	$129,660 $361.17 p/Share	359 Added 40.11%	536 Common Stock
Oct 17 2022	BUY Grant, award, or other acquisition	$9,983 $332.76 p/Share	30 Added 14.49%	177 Common Stock
Sep 19 2022	BUY Grant, award, or other acquisition	$10,068 $305.09 p/Share	33 Added 18.33%	147 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	$10,046 $313.94 p/Share	32 Added 21.92%	114 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	$9,975 $321.77 p/Share	31 Added 27.43%	82 Common Stock
Jun 21 2022	BUY Grant, award, or other acquisition	$9,812 $297.34 p/Share	33 Added 39.29%	51 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	$5,389 $299.38 p/Share	18 Added 50.0%	18 Common Stock

Also insider at

VEEV

VEEVA SYSTEMS INC Healthcare

Director

CNTA

Centessa Pharmaceuticals plc Healthcare

Director

MLH